PharmaNutra
€70.50Change from previous close: −0.98%Absolute change: −€0.70
At a glance
- Revenue growth
- +13.83%
- 2025 vs 2024
- Net income growth
- +20.44%
- 2025 vs 2024
- Net margin
- 15.0%
- 2024: 14.2%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 19.6 | 20.4 | 12.1 | 17.5 | — |
| Depreciation and amortization | 3.4 | 3.9 | 3.1 | 1.1 | — |
| Capital expenditure | -3.1 | -4.3 | -13.2 | -26.2 | — |
| Investing cash flow | -3.4 | -2.2 | -14.7 | -26.7 | — |
| Financing cash flow | -13.1 | -21.6 | -0.5 | 1.9 | — |
| Dividends paid | -9.6 | -8.2 | -7.7 | -6.9 | — |
| Share repurchases | -1.3 | -0.6 | -1.7 | -2.4 | — |
| Debt issued | — | — | 9.8 | 15.2 | 5.1 |
| Debt repaid | — | — | -0.4 | -3.8 | -0.7 |
| Net change in cash | 3.1 | -3.4 | -3.1 | -7.4 | — |
| Free cash flow | 16.4 | 16.2 | -1.2 | -8.7 | — |